(PharmaNewsWire.Com, June 06, 2022 ) The report "Antimicrobial Plastics Market by Type (Commodity Plastics, Engineering Plastics, and High Performance Plastics), Application (Packaging, Automotive, Consumer Goods, Medical and Healthcare, and Building & Construction), Region - Global Forecast to 2025", is projected to reach USD 59.8 billion by 2025 from USD 36.9 billion in 2020, at a CAGR of 10.1%. Antimicrobial plastics are polymer materials infused with antimicrobial agents and additives to kill microorganisms, such as bacteria, algae, and fungi, and inhibit their growth in end-use products. The continuous and repeated use of plastic materials causes issues related to hygiene, thereby increasing the risk of contamination and pathogenic diseases.
The major factors driving the antimicrobial plastics market are the growing awareness about health-related issues, rapid urbanization, growing population, increasing demand from the healthcare sector, and wide application areas of antimicrobial plastics.
The commodity plastics segment is estimated to be the largest type segment of the antimicrobial plastics market in 2019.
Commodity plastics are the most commonly used plastics across a wide range of applications. These plastics are used in applications where mechanical properties and service environments are not very critical. Some examples of commodity plastics are PE, PP, PS, PVC, PMMA, PET, and PUR. These plastics are produced in high volume at low cost for the most common disposable items and durable goods. The widespread applications, easy availability, and low-cost materials are the key factors driving the commodity plastics market.
The medical and healthcare application segment is estimated to lead the antimicrobial plastics market during the forecast period.
The medical and healthcare application leads the antimicrobial plastics market owing to consumer awareness regarding health-related issues and life-threatening diseases such as H1N1, nosocomial infections, and COVID-19 in the recent past. As a result, the importance of antimicrobial plastics in medical and healthcare application is expected to increase during the forecast period. Moreover, innovation in the medical and healthcare application, for instance, the development of non-toxic plastic equipment is anticipated to fuel the growth of the antimicrobial plastics market. Surgical and medical devices such as catheters, cubicle curtains, beds, and dental implants are the other medical and healthcare applications of antimicrobial plastics.
Browse in-depth TOC on "Antimicrobial Plastics Market” 146 - Market Data Tables 34 - Figures 171 - Pages
APAC is estimated to account for the largest share of the antimicrobial plastics market during the forecast period
APAC is the largest and fastest-growing antimicrobial plastics market. Growing industrialization, backed by infrastructure development in the region, has offered enormous opportunities for the use of antimicrobial plastics in APAC. The growing demand and policies, such as emission control and use of environmentally-friendly products, have led to innovation in the plastics industry of the region, making it a plastics hub, globally. The growing population, along with industry alliances, is expected to lead to significant growth of the antimicrobial plastics market in the region.
Major players profiled in the report include DuPont (US), BASF SE (Germany), Lonza Group (Switzerland), Avient Corporation (US), Microban International (US), Parx Plastics (Netherlands), King Plastic Corporation (US), BioCote (UK), Milliken Chemical (US) and Sanitized AG (Switzerland).
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.
Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the “Growth Engagement Model – GEM”. The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write “Attack, avoid and defend” strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.
MarketsandMarkets’s flagship competitive intelligence and market research platform, “Knowledge Store” connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including: